Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib
Jedeszko, C., Paez-Ribes, M., Di Desidero, T., Man, S., Lee, C. R., Xu, P., Bjarnason, G. A., Bocci, G., Kerbel, R. S.Volume:
7
Language:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.3010722
Date:
April, 2015
File:
PDF, 7.74 MB
english, 2015